The National Institutes of Health (NIH) has approved 13 new stem cell lines for use in agency-funded research.
The move follows a March 2009 order by President Obama that expanded the NIH's ability to fund stem cell research. Previously, an order by President Bush in 2001 had limited federal funding of stem cell research to studies of 60 existing lines of cells.
The new lines were approved based on the NIH Guidelines for Human Stem Cell Research adopted in July 2009 (http://stemcells.nih.gov/policy/2009guidelines.htm). These guidelines require that stem cell lines used in federal research be derived from embryos donated by individuals who gave informed consent. The NIH is considering whether to approve an additional 96 cell lines.
The NIH’s action will allow more than 30 of the 2009 NIH grantees to commence their research using one of the newly approved lines. The funded research includes use of human embryonic stem cells to regenerate damaged heart tissue and the development of systems to grow neural stem cells and neurons.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.